References
- Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health 2013; 34: 205-16. doi: 10.1146/annurev-publhealth-031811-124704
- Vainio H. Epidemics of asbestos-related diseases - something old, something new. Scand J Work Environ Health 2015; 41: 1-4. doi: 10.5271/sjweh.3471
- Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992; 12: 293-315. doi: 10.1016/0891-5849(92)90117-y
- Kinnula VL. Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. Eur Respir J 1999; 14: 706-16. doi: 10.1034/j.1399-3003.1999.14c35.x
- Solbes E, Harper RW. Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease. J Investig Med 2018; 66: 721-7. doi: 10.1136/jim-2017-000628
- Nichenametla SN, Muscat JE, Liao JG, Lazarus P, Richie JP, Jr. A functional trinucleotide repeat polymorphism in the 5’-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers. Mol Carcinog 2013; 52: 791-9. doi: 10.1002/mc.21923
- Zhang H, Liu H, Zhou L, Yuen J, Forman HJ. Temporal changes in glutathione biosynthesis during the lipopolysaccharide-induced inflammatory response of THP-1 macrophages. Free Radic Biol Med 2017; 113: 304-10. doi: 10.1016/j.freeradbiomed.2017.10.010
- Ketterer B. A bird’s eye view of the glutathione transferase field. Chem Biol Interact 2001; 138: 27-42. doi: 10.1016/s0009-2797(01)00277-0
- Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res 2001; 482: 21-6. doi: 10.1016/s0027-5107(01)00206-8
- Chen Y, Shertzer HG, Schneider SN, Nebert DW, Dalton TP. Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J Biol Chem 2005; 280: 33766-74. doi: 10.1074/jbc.M504604200
- Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013; 2013: 972913. doi: 10.1155/2013/972913
- Zmorzynski S, Swiderska-Kolacz G, Koczkodaj D, Filip AA. Significance of polymorphisms and expression of enzyme-encoding genes related to glutathione in hematopoietic cancers and solid tumors. Biomed Res Int 2015; 2015: 853573. doi: 10.1155/2015/853573
- Flanagan JU, Smythe ML. Sigma-class glutathione transferases. Drug Metab Rev 2011; 43: 194-214. doi: 10.3109/03602532.2011.560157
- Tan XL, Moslehi R, Han W, Spivack SD. Haplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancer. Cancer Detect Prev 2009; 32: 403-15. doi: 10.1016/j.cdp.2009.02.004
- Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000; 61: 154-66. doi: 10.1159/000028396
- Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, et al. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 1996; 88: 1853-6. doi: 10.1093/jnci/88.24.1853
- Koide S, Kugiyama K, Sugiyama S, Nakamura S, Fukushima H, Honda O, et al. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol 2003; 41: 539-45. doi: 10.1016/s0735-1097(02)02866-8
- Yuniastuti A, Susanti R, Mustikaningtyas D. Polymorphism of glutamate-cysteine ligase subunit catalytic (GCLC) gene in pulmonary tuberculosis patients. Pak J Biol Sci 2017; 20: 397-402. doi: 10.3923/pjbs.2017.397.402
- Skvortsova L, Perfelyeva A, Khussainova E, Mansharipova A, Forman HJ, Djansugurova L. Association of GCLM -588C/T and GCLC -129T/C promoter polymorphisms of genes coding the subunits of glutamate cysteine ligase with ischemic heart disease development in Kazakhstan population. Dis Markers 2017; 2017: 4209257. doi: 10.1155/2017/4209257
- Li J, Yin F, Lin Y, Gao M, Wang L, Liu S, et al. Genetic susceptibility analysis of GCLC rs17883901 polymorphism to preeclampsia in Chinese Han women. Gynecol Endocrinol 2020; 36: 781-5. doi: 10.1080/09513590.2020.1725970
- Vieira SM, Monteiro MB, Marques T, Luna AM, Fortes MA, Nery M, et al. Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus. BMC Med Genet 2011; 12: 129. doi: 10.1186/1471-2350-12-129
- Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51-88. doi: 10.1146/annurev.pharm-tox.45.120403.095857
- Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997; 272: 10004-12. doi: 10.1074/jbc.272.15.10004
- Hirvonen A, Pelin K, Tammilehto L, Karjalainen A, Mattson K, Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 1995; 55: 2981-3. PMID: 7606714
- Landi S, Gemignani F, Neri M, Barale R, Bonassi S, Bottari F, et al. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int J Cancer 2007; 120: 2739-43. doi: 10.1002/ijc.22590
- Kukkonen MK, Hamalainen S, Kaleva S, Vehmas T, Huuskonen MS, Oksa P, et al. Genetic susceptibility to asbestos-related fibrotic pleuropulmonary changes. Eur Respir J 2011; 38: 672-8. doi: 10.1183/09031936.00049810
- Franko A, Dodic-Fikfak M, Arneric N, Dolzan V. Glutathione S-transferases GSTM1 and GSTT1 polymorphisms and asbestosis. J Occup Environ Med 2007; 49: 667-71. doi: 10.1097/JOM.0b013e318065b855
- Franko A, Dolzan V, Arneric N, Dodic-Fikfak M. The influence of genetic polymorphisms of GSTP1 on the development of asbestosis. J Occup Environ Med 2008; 50: 7-12. doi: 10.1097/JOM.0b013e31815cbab5
- Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 187-91. doi: 10.1097/00008571-199604000-00005
- Jakobsson K, Rannug A, Alexandrie AK, Rylander L, Albin M, Hagmar L. Genetic polymorphism for glutathione-S-transferase mu in asbestos cement workers. Occup Environ Med 1994; 51: 812-6. doi: 10.1136/oem.51.12.812
- Jamrozik E, de Klerk N, Musk AW. Asbestos-related disease. Intern Med J 2011; 41: 372-80. doi: 10.1111/j.1445-5994.2011.02451.x
- Frank AL, Joshi TK. The global spread of asbestos. Ann Glob Health 2014; 80: 257-62. doi: 10.1016/j.aogh.2014.09.016
- Lacourt A, Lévêque E, Guichard E, Gilg Soit Ilg A, Sylvestre MP, Leffondré K. Dose-time-response association between occupational asbestos exposure and pleural mesothelioma. Occup Environ Med 2017; 74: 691-7. doi: 10.1136/oemed-2016-104133
- Ulvestad B, Kjærheim K, Martinsen JI, Damberg G, Wannag A, Mowe G, et al. Cancer incidence among workers in the asbestos-cement producing industry in Norway. Scand J Work Environ Health 2002; 28: 411-7. doi: 10.5271/sjweh.693
- Nishimura Y, Kumagai-Takei N, Matsuzaki H, Lee S, Maeda M, Kishimoto T, et al. Functional alteration of natural killer cells and cytotoxic T lymphocytes upon asbestos exposure and in malignant mesothelioma patients. Biomed Res Int 2015; 2015: 238431. doi: 10.1155/2015/238431
- Rosner D, Markowitz G, Chowkwanyun M. “Nondetected”: the politics of measurement of asbestos in talc, 1971-1976. Am J Public Health 2019; 109: 969-74. doi: 10.2105/ajph.2019.305085
- Pairon JC, Laurent F, Rinaldo M, Clin B, Andujar P, Ameille J, et al. Pleural plaques and the risk of pleural mesothelioma. J Natl Cancer Inst 2013; 105: 293-301. doi: 10.1093/jnci/djs513
- Maxim LD, Niebo R, Utell MJ. Are pleural plaques an appropriate endpoint for risk analyses? Inhal Toxicol 2015; 27: 321-34. doi: 10.3109/08958378.2015.1051640